Riskpilot← Back to searchSign inGet full accessEvosep ApS
APSActiveCVR 37510068Billedskærervej 15Research and experimental development on natural sciences and engineering · NACE 7210Est. 201666 employeeshttps://www.evosep.com/
Revenue 2025
DKK 72,4M
+68% vs 2024
EBITDA margin
-316.0%
-82358% vs 2024
Equity ratio
89.3%
Financial strength
Net profit 2025
DKK -221,6M
-8382% vs 2024
| Revenue | DKK 72,4M | +68% |
| EBITDA | DKK -228,7M | -82358% |
| Net profit | DKK -221,6M | -8382% |
| Total assets | DKK 173,1M | -35% |
| Equity | DKK 154,5M | -38% |
| Employees | 66 | — |
Legal name
Evosep ApS
CVR number
37510068
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. marts 2016
Share capital
DKK 207.131
Employees
66 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse.
Company purpose
Selskabets formål er udvikling og markedsføring af laboratorieudstyr, herunder måleinstrumenter og associarede forbrugsvarer samt aktiviteter i tilknytning hertil.
Address
Billedskærervej 15
Phone
+4526332021
Email
info@evosep.com
Website
https://www.evosep.com/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -1.203 | -2.722 | 2.510 | 9.017 | 21.644 | 36.908 | 53.510 | 60.355 | 43.124 | 72.369 |
| Staff expenses | -4.050 | -8.142 | -8.764 | -9.043 | -12.627 | -15.116 | -154.329 | -33.698 | -41.962 | -277.860 |
| EBITDA | -5.253 | -10.864 | -6.254 | -26 | 9.017 | 21.792 | -107.880 | 25.957 | 278 | -228.676 |
| Depreciation & amort. | 71 | -169 | -144 | -244 | -242 | -920 | -2.383 | -4.839 | -8.880 | -10.170 |
| EBIT | -5.324 | -11.033 | -6.399 | -270 | 8.775 | 20.872 | -110.264 | 21.118 | -8.602 | -238.846 |
| Net financials | -26 | -6 | 52 | 94 | -923 | 266 | 903 | 2.890 | 5.116 | -2.242 |
| Profit before tax | -5.350 | -11.040 | -6.346 | -176 | 7.852 | 21.139 | -109.361 | 24.008 | -3.486 | -241.088 |
| Tax | -1.155 | -2.426 | -1.395 | -35 | 1.683 | 4.463 | -29.741 | 4.231 | -873 | -19.451 |
| Net profit | -4.195 | -8.613 | -4.951 | -141 | 6.169 | 16.675 | -79.619 | 19.777 | -2.613 | -221.637 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8.708 | 9.632 | 24.686 | 24.116 | 36.957 | 56.768 | 112.240 | 275.300 | 265.917 | 173.069 |
| Equity | 7.855 | 7.229 | 22.510 | 22.369 | 28.538 | 45.214 | -34.406 | 252.714 | 249.889 | 154.548 |
| Long-term debt | 0 | 0 | 0 | 370 | 962 | 962 | 962 | 2.333 | 2.125 | 1.901 |
| Short-term debt | 853 | 2.403 | 2.176 | 1.377 | 7.347 | 10.352 | 145.683 | 20.173 | 13.903 | 16.620 |
| Total debt | 853 | 2.403 | 2.176 | 1.747 | 8.309 | 11.313 | 146.645 | 22.506 | 16.028 | 18.521 |
EBITDA margin
-316.0%
This company
15.8%
Market median
-2100% vs market
20162025
Equity ratio
89.3%
This company
38.2%
Market median
+134% vs market
20162025
Return on equity
-143.4%
This company
18.4%
Market median
-879% vs market
20162025
Net profit margin
-306.3%
This company
8.1%
Market median
-3881% vs market
20162025
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20162025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20162025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-03-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
CR Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2023 | — | — | |
OV | Chairman | 2023 | — | — |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Paradigm BidCo ApS | Company | 100.0% | 100.0% | 2025 |
Danmarks Eksport- og Investeringsfond | Company | 25.0% | 25.0% | 2023 |
VÆKSTFONDEN | Company | 25.0% | 25.0% | 2023 |
Novo Holdings A/S | Company | 20.0% | 20.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Paradigm MidCo 1 ApS
Evosep ApS Board members of Evosep ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Bern | Chief Executive Officer | 0 companies |
| Christian Ravnsborg | Chief Executive Officer | 0 companies |
| Tonni Bülow-Nielsen | Board of Directors | 0 companies |
| Stefan Karl Dieter Wolf | Chairman | 0 companies |
| Stephen Neil van Helden | Board of Directors | 0 companies |
| Ole Vorm | Chairman | 0 companies |
| Jens Bornhøft Christensen | Board of Directors | 0 companies |
| Daniel Mahony | Board of Directors | 0 companies |